Views & Analysis Why pharma isn’t yet achieving digital excellence, and how i... Nearly 70% of HCPs are now digital natives, with no interest in going back to pre-COVID sales engagement methods.
News Trial miss doesn't dent Biogen's faith in Alzheimer's drug Biogen will advance its tau-targeting Alzheimer's disease drug diranersen into phase 3, even though it missed the main endpoint in a midstage trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.